ACB has been the subject of several analyst reports. Cantor Fitzgerald upgraded Aurora Cannabis from a “neutral” rating to an “overweight” rating in a report on Friday, June 24th. CIBC reduced their target price on Aurora Cannabis from C$6.50 to C$3.75 in a report on Monday, May 16th. Finally, Stifel Nicolaus upgraded Aurora Cannabis from a “sell” rating to a “hold” rating and set a $2.15 target price on the stock in a report on Monday, June 6th.
Aurora Cannabis Trade Down 1.3%
Shares of ACB stock opened at $1.50 on Friday. Aurora Cannabis has a 52 week low of $1.21 and a 52 week high of $8.69. The company has a quick ratio of 4.76, a current ratio of 5.85, and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average is $1.43 and its two hundred day moving average is $2.83. The stock has a market cap of $340.20 million, a PE ratio of -0.32 and a beta of 2.74.
Aurora Cannabis (NYSE:ACB – Get Rating) last announced its earnings results on Thursday, May 12th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.88). Aurora Cannabis had a negative return on equity of 25.80% and a negative net margin of 542.50%. The business had revenue of $39.82 million during the quarter, compared to analyst estimates of $40.58 million. research analysts anticipate that Aurora Cannabis will post -1.65 earnings per share for the current fiscal year.
Aurora Institutional Cannabis Trade
Institutional investors and hedge funds have recently bought and sold shares of the stock. Horan Securities Inc. acquired a new position in shares of Aurora Cannabis during the fourth quarter worth about $54,000. Gotham Asset Management LLC purchased a new stake in shares of Aurora Cannabis during the fourth quarter valued at approximately $64,000. City State Bank bought a new position in Aurora Cannabis in the fourth quarter worth $40,000. MQS Management LLC bought a new position in Aurora Cannabis during the first quarter worth $49,000. Finally, HighTower Advisors LLC bought a new position in Aurora Cannabis in the first quarter worth $50,000. Currently, 15.47% of the shares are owned by hedge funds and other institutional investors.
Aurora Cannabis company profile
(get a score)
Aurora Cannabis Inc produces, distributes and sells cannabis and cannabis-derived products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale and retail distribution activities. The company produces various varieties of dry cannabis, cannabis oil and capsules, and topical kits for medical patients.
Recommended stories
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reporting. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should you invest $1,000 in Aurora Cannabis right now?
Before you consider Aurora Cannabis, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients daily. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Aurora Cannabis wasn’t on the list.
Although Aurora Cannabis currently has a “Hold” rating among analysts, the top rated analysts believe these five stocks are best buys.
Check out the 5 stocks here
